Paolo Fortina Selected Research

Paolo Fortina Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 08/2005
9	Breast Neoplasms (Breast Cancer) 10/2017 - 11/2009
7	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 04/2010
5	Leukemia 01/2022 - 08/2015
4	Carcinogenesis 04/2015 - 10/2011
3	Neuroblastoma 01/2020 - 02/2007
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
3	Circulating Neoplastic Cells 10/2017 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2020
2	Neuroinflammatory Diseases 01/2021 - 10/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 10/2020
2	Ichthyosis (Xeroderma) 01/2019 - 11/2017
2	Aneuploidy (Aneuploid) 04/2015 - 03/2012
2	Chromosomal Instability (Chromosome Stability) 04/2015 - 03/2012
2	Inflammation (Inflammations) 08/2014 - 06/2010
2	Melanoma (Melanoma, Malignant) 12/2013 - 05/2013
2	Neoplasm Metastasis (Metastasis) 06/2013 - 12/2006
2	beta-Thalassemia (Cooley's Anemia) 10/2008 - 12/2002
2	Colorectal Neoplasms (Colorectal Cancer) 04/2007 - 12/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Multiple Sclerosis 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Neutropenia 01/2020
1	ST Elevation Myocardial Infarction 12/2019
1	Myocardial Infarction 12/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Epidermodysplasia Verruciformis 01/2019
1	Epidermolysis Bullosa 01/2018
1	Poikiloderma of Kindler 01/2018
1	Acute Coronary Syndrome 01/2018
1	Hemorrhage 01/2018
1	Philadelphia Chromosome 01/2018
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2017
1	Disease Progression 09/2016
1	Adenocarcinoma 04/2015
1	Retinoblastoma (Glioblastoma, Retinal) 11/2014
1	Complex Regional Pain Syndromes 08/2014
1	Chronic Pain 08/2014

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2002
7	Proteins (Proteins, Gene)FDA Link 06/2013 - 12/2008
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2010
4	Biomarkers (Surrogate Marker)IBA 09/2016 - 11/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 10/2020
3	Phosphotransferases (Kinase)IBA 01/2019 - 04/2015
3	Cyclin D1IBA 04/2015 - 03/2012
3	MicroRNAs (MicroRNA)IBA 08/2014 - 05/2008
3	Caveolin 1IBA 09/2011 - 08/2008
2	ChromatinIBA 01/2022 - 01/2020
2	IntegrinsIBA 05/2020 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
2	CytokinesIBA 01/2020 - 08/2014
2	Estrogen ReceptorsIBA 10/2017 - 09/2011
2	RNA (Ribonucleic Acid)IBA 01/2017 - 10/2002
2	Hormones (Hormone)IBA 11/2014 - 09/2011
2	Phenobarbital (Luminal)FDA Link 01/2013 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 12/2008 - 08/2008
2	LipidsIBA 12/2008 - 08/2008
2	Enterotoxin ReceptorsIBA 04/2007 - 12/2006
2	Factor VII (Proconvertin)IBA 03/2003 - 12/2002
1	Histone MethyltransferasesIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Nonsense Codon (Nonsense Mutation)IBA 06/2021
1	Interleukin-12 (IL 12)IBA 10/2020
1	InterferonsIBA 10/2020
1	palbociclibIBA 01/2020
1	snake venom protein C activatorIBA 01/2020
1	Cyclin-Dependent Kinase 4IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	SteroidsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	histone H3 trimethyl Lys4IBA 01/2020
1	S100A12 ProteinIBA 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	InterleukinsIBA 01/2019
1	vorapaxarIBA 01/2018
1	protease-activated receptor 4IBA 01/2018
1	TetraspaninsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Estrogen Receptor alphaIBA 10/2017
1	Histones (Histone)IBA 01/2017
1	Collagen Type VIIIBA 01/2017
1	Deoxyribonucleases (DNase)FDA Link 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Nucleic AcidsIBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 08/2015
1	Small Interfering RNA (siRNA)IBA 11/2014
1	LipopolysaccharidesIBA 08/2014
1	dabrafenibIBA 12/2013
1	Mitogen-Activated Protein KinasesIBA 12/2013
1	VemurafenibIBA 12/2013

Therapy/Procedure

20	Therapeutics 06/2021 - 12/2006
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Radiotherapy 11/2014 - 09/2011
1	Lab-On-A-Chip Devices 01/2016
1	Aftercare (After-Treatment) 11/2014